NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
30/12/2017
Voltar para busca
Dado oficial do USPTO
MEDA
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
MEDA
ST13
US500000077234664Classe
5, 10, 35, 42, 44
Pedido
77234664
Registro
3536003
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
49
Atualização mais recente
30/12/2017
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 10, 35, 42, 44
Data de depósito
20/07/2007
Data de registro
25/11/2008
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
30/12/2017
Última transação
30/12/2017
Escritório responsável
United States Patent and Trademark Office
Código da situação
800
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Código do desenho
4
Tipo de titular
03
Localização do titular
Solona, SE
Examinador
FAHRENKOPF, PAUL
Unidade examinadora
L10
Localização atual
GENERIC WEB UPDATE
Titulares e representantes
Titulares
Meda AB
Representantes
Mylan Inc. IP Department - Trademarks Mylan
Classificação técnica
Classes Nice
Classe 5Classe 10Classe 35Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical productspharmaceutical preparations for the prevention and treatment of disorders and diseases of the brain and the nervous systemthe eyesthe respiratory tractthe immune system and the skin; analgesicanti-rheumaticanti-inflammatoryanti-allergicneurological and cardiovascular medicine; pharmaceutical preparationsantidiabetics; pharmaceutical preparations for the treatment of diseases of the central nervous system; Pharmaceutical Drugs Containing Chamomile for the Treatment of Disorders of the SkinEarsGums and MouthRespiratoryGastro-Intestinal and Urogenital Systems; pharmaceutical preparationsantibiotics; pharmaceutical preparations for the treatment of infections; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for the treatment of urogenital diseases and disorders; sanitary preparations for medical use; medical plasters and wound dressings
Classe 10
Medical apparatus for facilitating the inhalation of pharmaceutical preparations; Medical apparatus for introducing pharmaceutical preparations into the human body; Medical apparatus for treating respiratory conditions; Medical inhalers for therapeutic use sold empty
Classe 35
Managementbusiness managementbusiness management planningbusiness management and advicebusiness management consultancy services
Classe 42
Scientific research; Scientific researchconducting clinical trials; Scientific research in the field of pharmaceuticals and clinical trials; Technological servicesdesign and testing for new product development; Technological servicesdesign and testing of new products for others; Industry analysis and research servicespharmaceutical drug development services; pharmaceutical product evaluation; pharmaceutical research and developmentpharmaceutical research services and testing; inspection or research of pharmaceuticals
Classe 44
Medical services; health care; providing information about health care
Publicações
Histórico de despachos e eventos da marca no USPTO.
49 publicações encontradas
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
30/12/2017
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
30/12/2017
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
30/12/2017
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/12/2017
E89R
TEAS SECTION 8 & 9 RECEIVED
01/12/2017
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
25/11/2017
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/02/2017
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/02/2017
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
20/02/2015
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
20/02/2015
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
20/02/2015
E815
TEAS SECTION 8 & 15 RECEIVED
04/02/2015
R.PR
REGISTERED-PRINCIPAL REGISTER
25/11/2008
DP1B
1(B) BASIS DELETED; PROCEED TO REGISTRATION
21/10/2008
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
21/10/2008
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
21/10/2008
IUCN
NOTICE OF ALLOWANCE CANCELLED
20/10/2008
D1BR
TEAS DELETE 1(B) BASIS RECEIVED
20/10/2008
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
15/10/2008
UNDC
UNDELIVERABLE MAIL - COURTESY COPY MAILED
10/10/2008
NOAM
NOA MAILED - SOU REQUIRED FROM APPLICANT
07/10/2008
PUBO
PUBLISHED FOR OPPOSITION
15/07/2008
NPUB
NOTICE OF PUBLICATION
25/06/2008
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
09/06/2008
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/06/2008
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
15/05/2008
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
12/05/2008
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
30/04/2008
ALIE
ASSIGNED TO LIE
30/04/2008
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
30/04/2008
XAEC
EXAMINER'S AMENDMENT ENTERED
30/04/2008
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
30/04/2008
GNEA
EXAMINERS AMENDMENT E-MAILED
30/04/2008
CNEA
EXAMINERS AMENDMENT -WRITTEN
30/04/2008
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
28/03/2008
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
28/03/2008
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
28/03/2008
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
28/01/2008
GNSL
LETTER OF SUSPENSION E-MAILED
28/01/2008
CNSL
SUSPENSION LETTER WRITTEN
28/01/2008
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
31/12/2007
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
31/12/2007
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
31/12/2007
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/11/2007
GNRT
NON-FINAL ACTION E-MAILED
02/11/2007
CNRT
NON-FINAL ACTION WRITTEN
02/11/2007
DOCK
ASSIGNED TO EXAMINER
25/10/2007
NWAP
NEW APPLICATION ENTERED
25/07/2007
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace MEDA ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.